Navigation Links
Understanding the biological and ecological implications of safe nanotechnology
Date:8/6/2012

Nanoscale science and technology has seen exciting advances recently in drug delivery, electronics, energy and environmental applications. According to international scientific conventions, nanomaterials are those whose at least one dimension is less than or equal to 10-9 m. At the same time, there is a great possibility for nanomaterials to enter ecosystems at the points of use or disposal, which could lead to negative environmental implications.

Our recent paper, "Dendrimer-fullerenol soft-condensed nanoassembly" published in The Journal of Physical Chemistry C, showed how the soft nanomaterial dendrimer can be used to remediate the environment from potentially toxic nanomaterials. Here, we used fullerenol a 60 carbon molecule in the shape of a buckyball and functionalized with hydroxyl groups as a model system. Such an assembly also has implications for drug delivery.

We found that the assemblies of dendrimers and fullerenols were strong, spontaneous, and thermodynamically favorable at neutral water pH and ambient temperature and pressure.

Dendrimers are highly branched, polymeric macromolecules with a high degree of surface functionalities. Their branching determines their generation number (G) the higher the generation, the greater the degree of surface functionalities. We used both G1 and G4 poly(amidoamine) (PAMAM) dendrimers and found that both these dendrimers hosted one fullerenol per primary amine on the dendrimer surfaces. However, G4 PAMAM dendrimers hosted fullerenols 40 times better than G1, simply because of their higher degree of surface functionalities. Based on our findings, we recommended proper loading capacities of fullerenols for G1 and G4 dendrimers in drug delivery and environmental remediation.

With the advent of new technologies, the public often becomes skeptical of their implications on the environment. In our group, we strive to understand the biological and ecological implications
'/>"/>

Contact: Brian Mullen
mullen2@clemson.edu
864-656-2063
Clemson University
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Joslin researchers gain new understanding of diabetes and kidney disease
2. Stem cell research aids understanding of cancer
3. Discovery increases understanding how bacteria spread: U of A study
4. Understanding faults and volcanics, plus life inside a rock
5. New understanding of terrestrial formation has significant and far reaching future implications
6. A trained palate: Understanding complexities of taste, smell could lead to improved diet
7. Zebrafish could hold the key to understanding psychiatric disorders
8. Understanding the RNAi Reagents Market Overlap with Drug Discovery and Therapeutic Development is Critical for Pharmaceutical Leaders
9. Understanding why some people have propensity to disease
10. New data improve understanding of breast cancers multiple varieties
11. New genetically engineered mice aid understanding of incurable neuromuscular disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Understanding the biological and ecological implications of safe nanotechnology
(Date:12/17/2014)... , Dec. 16, 2014  Automation is ... this more evident than at international borders. Over ... document scanners have allowed veteran travelers to self ... Passport Control (APC) Kiosks at an increasing number ... globe. According to Maxine ...
(Date:12/11/2014)... 2014  That blood pressure plays a role in human ... the medical term for high blood pressure – was first ... inflatable cuff that,s used in measuring blood pressure was invented ... new about hypertension, its triggers and its effects. In fact, ... and the best ways to treat it. For ...
(Date:12/10/2014)... Forest Baptist Medical Center today announced plans for a ... Funding for this $50 million capital project is part ... launched next summer. The medical education ... R.J. Reynolds Tobacco Company complex, adjacent to 525@vine in ... plans to be ready to welcome medical students in ...
Breaking Biology News(10 mins):Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
... consider giving thanks for the bacteria-busting ability of cranberry ... beverage holds important clues for preventing cavities. , ... D.D.S., Ph.D., at the University of Rochester Medical Center ... juice a powerful weapon against bladder infections also hold ...
... : It makes me sad when an article that should ... webpage of the student's group in the iGEM competition , ... for their bacterial 'camera'. , Using Petri dishes full ... at The University of Texas at Austin and UCSF successfully ...
... College of Medicine and the German Cancer Research Institute ... regions of a cell--a process crucial for the cellular ... metastasis. Their study appears in the November 24 issue ... Singer and Dr Stefan Huettelmaier, the research team focused ...
Cached Biology News:Give thanks for the cranberry, say dental researchers 2Give thanks for the cranberry, say dental researchers 3Student scientists create living bacterial photographs 2Student scientists create living bacterial photographs 3Einstein scientists discover how protein crucial for motion is synthesised at the right place in the cell 2
(Date:12/24/2014)... LOUIS , Dec. 23, 2014 ... today that the waiting period under the Hart-Scott-Rodino ... the acquisition expired on December 22, 2014, thereby ... review requirement for the acquisition of the Company ... U.S. antitrust clearance satisfies another condition to closing ...
(Date:12/22/2014)... 22, 2014   Synthetic Biologics, Inc. ... pathogen-specific therapies for serious infections and diseases, ... today announced positive topline safety and tolerability ... of SYN-004, the Company,s investigational oral beta-lactamase ... difficile (C. difficile) infection, antibiotic-associated diarrhea ...
(Date:12/22/2014)... , Dec. 22, 2014  ( www.competitivehealth.com ) ... an online medical bill review and advocacy service, has ... the FREE WellCard Savings discount health services marketplace. ... that was more than they expected to pay. As ... health care costs, WellCard Savings is pleased to offer ...
(Date:12/19/2014)... 19, 2014 Bioject Medical Technologies ... manufacturer of needle-free injection technology, today announced that ... Therapeutics, Inc. (“ITI”) for ITI to use the ... LAMP™ vaccine platform. , In the agreement, ... license to the Biojector®-2000 that triggers based on ...
Breaking Biology Technology:Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 3
... , , , ALBANY, Ore., ... financial results for the first quarter of fiscal 2010, which ended ... a 5% decrease compared to revenue of $4.9 million in the ... quarter was $1.0 million, compared to operating income of $314,000 for ...
... Md., Aug. 6 GenVec, Inc. (Nasdaq: GNVC ) today ... , , (Logo: http://www.newscom.com/cgi-bin/prnh/20081205/DC50112LOGO ... net loss of $4.8 million ($0.05 per share) for the three months ... ($0.08 per share) in the comparable quarter of 2008. For the six ...
... 6 Novavax, Inc. (Nasdaq: NVAX ) announced ... Chief Financial Officer and treasurer. Mr. Driscoll will report ... , , Previously Mr. Driscoll served as ... Genelabs Technologies, Inc. Prior to his position at Genelabs, ...
Cached Biology Technology:Synthetech Reports First Quarter Fiscal 2010 Results 2Synthetech Reports First Quarter Fiscal 2010 Results 3Synthetech Reports First Quarter Fiscal 2010 Results 4Synthetech Reports First Quarter Fiscal 2010 Results 5Synthetech Reports First Quarter Fiscal 2010 Results 6GenVec Reports Second Quarter 2009 Financial Results 2GenVec Reports Second Quarter 2009 Financial Results 3GenVec Reports Second Quarter 2009 Financial Results 4GenVec Reports Second Quarter 2009 Financial Results 5GenVec Reports Second Quarter 2009 Financial Results 6GenVec Reports Second Quarter 2009 Financial Results 7Novavax Announces Appointment of Frederick W. Driscoll as Vice President, Chief Financial Officer and Treasurer 2
Anti Autotaxin /ENPP2 , - (Rabbit)...
Mouse polyclonal antibody to TNPO2 - transportin 2 (importin 3, karyopherin beta 2b)...
...
Mouse monoclonal antibody to ALAS2 - aminolevulinate, delta-, synthase 2 (sideroblastic/hypochromic anemia)...
Biology Products: